Following the Hyundai Chairless Exoskeleton (H-CEX) demonstration conducted at the Hyundai-KIA North American factory last August, the company plans to verify H-VEX’s success through extensive testing at the end of 2018.
In early 2018, Hyundai Motor Group identified Robot-Artificial Intelligence as one of five areas of future innovation and growth. The company established a designated robotics team in its strategic technology headquarters to focus on the development of related tech, and is expanding its cooperation with associated sectors.
Hyundai Motor Group is developing technology in three areas of robotics: wearable robots, service robots, and micro-mobility. The company is also working in partnership with other talented domestic and international companies that possess robotic and artificial intelligence technology.
The first H-CEX was developed for industrial use. It is a knee-joint protective device that helps maintain a worker’s sitting position. Weighing in at 1.6kg it is light yet highly durable, and can withstand weights of up to 150kg. With waist, thigh and knee belts it can be easily fitted and adjusted to the user’s height.
Along with the H-CEX, the Hyundai Motor Group team plan to test and apply the H-VEX in its North American factories at the end of the year. H-VEX is a device that alleviates pressure on workers’ neck and back by adding 60kg of strength to the user when their arms are used overhead. It is expected to be very effective at preventing injury and increasing work efficiency.
There are a variety of applications and fields that robots can be developed for, such as wearables, service robots and micro mobility. Hyundai Motor Group showcased the Hyundai Medical Exoskeleton (H-MEX), which assists paraplegics and elderly people with walking and traversing staircases, at the 2017 International Consumer Electronics Show (CES). It is currently in the process of being approved by the Ministry of Food and Drug Safety in Korea, and by the U.S. Food and Drug Administration, for commercialization as a medical device.
Another Hyundai Motor Group development in robotics, the Hyundai Universal Medical Assist (HUMA), can be applied to the waist and legs to strengthen the muscles while walking, enabling users to achieve a running speed of 12km/h and making it one of the fastest wearable robots in the world.
Other than wearables, robots that can improve the quality of a user’s life are being created. The ‘Hotel Service Robot’ can, among other functions, take care of room service and guide guests around a hotel. The robots will be tested at the end of the year at South Korea’s Haevichi hotel and resort, and the Rolling Hills hotel.
The ‘Sales Service Robot’ that was modelled last year can explain car details to customers. It is equipped a with natural language conversation system, artificial intelligence, and a mobility function, providing the ability to consult with customers about vehicle models in showrooms. It is currently in the design and development stage, and a prototype is expected to be available early next year. A prototype ‘electric vehicle charge manipulator’ that automatically charges an electric vehicle when it stops in front of the device, will also be previewed by 2020.
Hyundai Motor Group’s ‘robotic personal mobility’ is a next-generation single-person mobility platform so versatile it can slowly traverse with two wheels to avoid obstacles indoors, and then morph into a three-wheeled mode of transport with improved stability for use outdoors.
Hyundai Motor Group is making substantial investments in the robotics field, considering it one of the promising fields for mobility, and actively securing related technologies. On 10 September 2018 it initiated a strategic investment in the US-based artificial intelligence technology start-up Perceptive Automata to secure human movement prediction technology. The company is also cooperating with China’s top vision technology equipped artificial intelligence start-up, DeepGlint.
A $4.5 million (US dollar) ‘AI Alliance Fund’ was created in cooperation with SK Telecom and the Hanwha Asset Management company to invest in promising start-ups with competence in artificial intelligence and smart mobility.
Dr. Youngcho Chi, Executive Vice President of Strategy & Technology Division and Chief Innovation Officer of Hyundai Motor Group said, “The field of robotics has the potential to usher in a new era in our industry. The possibilities for the technology are endless – from future mobility solutions and industrial productivity aids to vital military applications, we think the future is better with robots. The huge collective experience within the Hyundai Motor Group will facilitate rapid progress in the coming years. We are excited about current developments, and very optimistic for the use of this technology to improve lives around the globe.”
Car tech rules CES Asia
More than 60 automotive brands will highlight their latest innovations at the Asia edition of CES in Shanghai in June.
The Consumer Technology Association (CTA) has revealed that vehicle technology show floor space at CES Asia 2019 will double in size and showcase technology advances which make cars safer and more connected.
More than 60 global auto brands including Audi, Honda, Hyundai, Kia and Nissan will feature their latest innovations in vehicle technology across two major indoor exhibit halls, the event’s largest-ever vehicle tech footprint. CES Asia attendees will experience the latest concept cars and connected vehicles from self-driving to all-electric, making transportation safer and greener. CES Asia will run from 11 to 13 June 2019 at the Shanghai New International Expo Centre Center (SNIEC) in Shanghai, China.
CES Asia show director John T. Kelley said: “Today, every company is a tech company. Traditional automotive manufacturers are joining vehicle tech newcomers to exhibit at CES Asia, the perfect platform that brings together different industries to showcase their latest technologies in self-driving, clean energy and smart navigation features. CES Asia uniquely challenges the traditional auto shows in targeting the world’s largest auto market – China.”
German auto giant Volkswagen will join forces with Beijing-based Mobvoi for their CES Asia debut showcasing the latest development of AI coming to Volkswagen’s future cars. Inceptio Technology is another first-time exhibitor to demonstrate next generation self-driving technologies for trucks and transportation services. Other first-time exhibitors include Denso, FAW Hongqi, Great Wall Motor, Hexagon Manufacturing Intelligence, Hyundai Mobis, and Polestar. 3M, Bose, Continental, NIRA Dynamics AB, OnStar, Opus Microsystems, Smart Eye AB and United Automotive Electronic Systems are just a few of the notable exhibitors returning to the automotive show floor at CES Asia 2019.
CES Asia 2019 will focus on AI, 5G, Vehicle Tech, and startups from around the world. The show is expected to feature 550+ exhibiting companies, including more than 125 startups and represents the full technology ecosystem with innovations spanning 20 product categories. For the fourth year in a row, the United States Department of Commerce (USDOC) has granted Trade Fair Certification for CES Asia 2019, a formal federal endorsement of CES Asia as a recognized opportunity to showcase U.S. products and services overseas.
Visit CESAsia.com to register now and find more event details. WeChat registration for CES Asia 2019 is also available now. Follow us on WeChat (ID: CESAsia_II) to register.
How cars can stop flu
The car of the future could help win the battle against superbugs – according to Jaguar Land Rover. Future models could help stop the spread of colds and flu thanks to innovative ultraviolet light technology (UV-C) borrowed from the medical industry, where it has been used for more than 70 years.
By integrating UV-C, Jaguar Land Rover believes it could help to stop bacteria and harmful viruses, known as pathogens, from surviving in the cabin. UV-C is currently widely used for disinfecting water, filtering air and sterilising surfaces by utilising wavelengths of light between 200 – 280 nanometres.
Exposing pathogens to UV-C within the air conditioning system breaks down the molecular structure of the DNA, neutralising them. Clean air is then released into the cabin. The technology could even help in the fight against drug-resistant superbugs.
Jaguar Land Rover is exploring UV-C technology as part of its vision to create a tranquil sanctuary inside each of its luxury vehicles. The manufacturer is piloting a wide range of driver and passenger wellbeing features, as it looks towards a self-driving future.
Dr Steve Iley, Jaguar Land Rover chief medical officer, said: “The average motorist spends as much as 300 hours per year behind the wheel. There is a clear opportunity to better utilise cars for administering preventative healthcare.”
“The implementation of individual wellbeing measures as part of our ‘tranquil sanctuary’ research promises to not only improve quality of life for our customers but in this case, offers clear advantages in reducing pathogen spread – protecting the overall population from the threat of disease; particularly as we move towards shared mobility solutions.”
Jaguar Land Rover is already actively seeking to neutralise pathogens in its latest generation Heating, Ventilation and Air Conditioning (HVAC) systems, available across the range including the all-electric Jaguar I-PACE and Range Rover Sport. The current Four-zone Climate Control and Cabin Air Ionisation system works by using high voltage to create trillions of nano-sized negatively charged particles (ions) coated in water molecules. These ions deactivate pathogens, forming larger particles which are removed from the air as they are brought back into the filter. As well as combatting pathogens, the ions also act upon odour molecules and allergens in a similar way.
Dr Iley said: “In the colder months infections are spread more easily, it’s reassuring to know that in your car at least, you can be confident that harmful pathogens are being neutralised.”
Recent medical trials* suggest the use of UV-C could be even more effective as it has been shown to cut the transmission of four major superbugs by up to 30%. Researchers focused on four drug-resistant organisms: MRSA, vancomycin-resistant enterococci (VRE), C. difficile and Acinetobacter.
Immunology expert, Dr. Hellmut Münch, CEO at Medical Enzyme Research Association, said: “The rise of superbugs and allergens is one of the largest threats we face as a species today. Investment in immunology is vital in ensuring that our immune systems stay ahead of the race against microorganisms, which are evolving far quicker than traditional pharmaceuticals can keep pace with. It is important that we continue to take an innovative look at how we can adapt our environment to help prevent the spread of the most harmful pathogens – which is why this research is paramount.”